Traditional diagnostic criteria for primary thrombocythaemia (PT) rema
in essentially negative, aiming to exclude other myeloproliferative di
sorders and causes of reactive thrombocytosis (RT). It would be useful
to have positive markers. We have examined several parameters to see
how well they discriminate between PT and RT. Three groups of patients
were studied: new, untreated PT (17), treated PT (12) and RT (17). Da
ta consisted of: ESR, plasma fibrinogen, factor VIIIC, von Willebrand
factor antigen (vWF:Ag), PDW, platelet nucleotide ratio (ATP:ADP) seru
m erythropoietin (Epo), ristocetin cofactor (vWF:RiCoF), multimeric st
ructure of VWF, interleukin-6, evidence of clinical ischaemia and eryt
hroid colony formation. Erythroid colonies were assayed in a serum-fre
e system with the addition of Epo, IL3 or alpha-IFN to produce a discr
iminant function (DF) successfully used in the diagnosis of primary po
lycythaemia in an earlier study. Acute phase reactants (ESR, fibrinoge
n, VIIIC, vWF:Ag) and IL6 were the best discriminants, while PDW and s
erum Epo were less so. ATP:ADP and clinical ischaemia were nondiscrimi
natory in this study. Reduction in vWF:RiCof and in high molecular wei
ght multimers were clearly associated with PT. Endogenous erythroid co
lonies were nondiscriminatory, but half the PT group and only one pati
ent in the RT group obtained a DF suggestive of myeloproliferative dis
order. Judicious use of a battery of tests may provide support for dia
gnosis of PT in difficult cases.